News & Updates from the National Brain Tumor Society
SNO-ing: Gathering at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology
This year's 4th Quadrennial Meeting of the World Federation of Neuro-Oncology, hosted in conjunction with the Society for Neuro-Oncology’s (SNO) Scientific Meeting and Education Day (Nov. 21 - 24) in San Francisco, just concluded and the National Brain Tumor Society contingent has returned from an intense and exciting week of meetings with a wealth of new knowledge and connections.
The Annual SNO Meeting has significantly grown in size and importance. Through the convening of attendees from across the country and around the world, it allows us to not only hear the latest in brain tumor science, but to also have many productive meetings and individual discussions with advisors, biopharma industry representatives, and other patient advocacy groups to help to advance our programmatic agenda and mission efficiently and effectively. We are proud to support the work of this critical organization.
National Brain Tumor Society Announces the Defeat GBM Research Collaborative's Project Plans and Investigator Teams
National Brain Tumor Society recently announced further details on our Defeat GBM Research Collaborative, which aims to double the five-year survival rate of patients with glioblastoma multiforme (GBM) - the most common and deadliest form of brain cancer - in just five years. Details include the nature of the four (4) simultaneous and synergistic projects that make up the overall Initiative, as well as the partner institution and/or lead principal investigators responsible for each. And just last week the Initiative got its own dedicated website: www.DefeatGBM.org
When The Cancer Genome Atlas (TCGA) launched in 2006, it was a huge moment for cancer research. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) had come together to deliver researchers a better understanding of the molecular basis of cancer through the application of genome analysis and sequencing technologies. The [...]
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.